Contact UsInvestorsCareersMediaContact Us
Pfizer In News ArchiveHomeNews & MediaPfizer In News ArchivePFIZER IN NEWS ARCHIVE


FDA authorises Pfizer vaccine for teens

Business Standard - Mumbai / Delhi / Pune / Bangalore / Hyderabad / Chennai / Kolkata / Kochi / Ahmedabad / Chandigarh(May 12)

US regulators expanded the use of Pfizers’ Covid-19 vaccine to children as young as 12 offering a way to protect the nations adolescents before they head back to school in the fall and paving the way for them to return to more normal activities.Read more

Sri Lanka approves Pfizer shot

The Hindu - Delhi / Mumbai / Bangalore / Hyderabad / Chennai / Kolkata / Kochi / Chandigarh(May 09)

Sri Lanka on Saturday approved Pfizers’ COVID-19 vaccine for emergency use in Sri Lanka as the island nation battles a third wave of the virus while suffering a restricted supply of vaccines from neighbouring India.Read more

Pfizer's Covid jab provides 95% protection, says study

Hindustan Times - Delhi / Mumbai / Pune / Chandigarh / Faridabad / Gurgaon / Noida(May 07)

The largest real-world study yet of the Pfizer-BioNTech vaccine on Thursday confirmed that the jab provided more than 95% protection against Covid-19 but found that the level dropped when people received just one of the two prescribed doses.Read more

Pfizer donates $70 mn supplies to india to aid covid treatment

Hindustan Times - Delhi / Mumbai / Chandigarh / Gurgaon(May 04)

Rhythma Kaul

US pharma giant Pfizer has donated medical supplies worth $70 million including drugs to treat the coronavirus disease (Covid-19) to India the company said in a statement on Monday adding that it was in talks with the Indian government to expedite its Covid-19 vaccine approval. Read more

Pfizer in talks with govt over 'expedited nod' for vaccine

The Indian Express - Delhi / Mumbai / Pune / Kolkata / Ahmedabad / Chandigarh(May 04)

PFIZER CHIEF Albert Bourla said on Monday the firm is donating medicines worth $70 million for treatment of Covid patients in India. We are deeply concerned by the critical Covid situation in India and our hearts go out to you your loved ones and all the people of India he said.Read more

Pfizer, Moderna vaccines could be soon in India

The Times Of India - Delhi(May 04)

Meanwhile the government said it has placed orders for 16 crore Covishield and Covaxin vaccines to be supplied in May-July. Adar Poonawalla said SII has govt orders to supply 11 crore more doses over the next few months. PII Read more

Pfizer donates USD 70 mn worth Covid-19 treatment drugs to India

(May 03)

sign in - Pfizer donates USD 70 mn worth Covid-19 treatment drugs to India Global pharma major Pfizer is sending its ... now Pfizer colleagues at distribution centres in the US Europe and Asia are hard at work rushing shipments of Pfizer... Read more

Confident Pfizer shot works against Indian variant: BioNTech co-founder

Hindustan Times - Delhi / Mumbai / Faridabad / Gurgaon / Noida(April 29)

BioNTech co-founder Ugur Sahin on Wednesday voiced confidence that the vaccine that his company jointly developed with Pfizer works against the Indian variant of the coronavirus. Read more

Pfizer offers vaccine to India govt at not-for-profit price

Hindustan Times - Mumbai(April 23)

Rhythma Kaul

People wait in a queue outside a Covid-19 vaccination centre in Goregaon Mumbai on Thursday. Read more

Pfizer: Will supply only through govt channels

The Indian Express - Delhi / Faridabad / Gurgaon / Noida(April 22)


PFIZER HAS decided to prioritise orders from the government, and supply doses of its Covid-19 vaccine “only through govern­ment contracts” in India. Read more

Pfizer vaccine is 'extraordinarily effective' against variants: Studies

Business Standard - Mumbai / Delhi / Bangalore / Kolkata / Chandigarh(May 08)


The studies, which are based on the real-world use of the vac­cine in Qatar and Israel, suggest that the vaccine can prevent the worst outcomes — including severe pneumonia and death — caused by B.l.1.7, the variant first identified in the UK, and B.1.351, the variant first identified in South Africa. Read more

Media Contacts

This information is intended for media professionals only. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may ONLY respond to calls and emails from professional journalists.

Email us at: [email protected]
Call us at: +91 - 022 - 6693 2000

If you are not a journalist, please visit Contact Us to reach the appropriate Pfizer contact.

About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.